Full Text
Budget Impact Analysis of Ustekinumab for the Treatment of Moderate to Severe Crohn’s Disease from a Brazilian Private Payer Perspective

Abstract

Authors

CO Fioratti E Asano RP Rosim

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×